The largest database of trusted experimental protocols

Compound 17

Compound 17 is a chemical entity of interest in biomedical research.
This AI-powered platform from PubCompare.ai can help optimize your Compound 17 research protocols by easily locating and comparing relevant protocols from literature, preprints, and patents.
Leverage advanced analysis to identify the best approach and accelerae your Compound 17 investigations.
Discvoer how this tool can support your research needs and make informed decisions with confidence.

Most cited protocols related to «Compound 17»

ADMETlab 2.0 provides a convenient and easy-to-use interface for users. Two services, Evaluation and Screening, are designed to support single-molecule and batch evaluation, whose input parameters and output information will be elaborated respectively.
In the Evaluation pattern, two molecular submission approaches are provided by pasting the SMILES string or drawing the chemical structure with the help of JMSE molecule editor (17 (link)). Once a user submits the job, the webserver will automatically standardize the input SMILES strings and compute all the endpoints. The prediction results are mainly displayed in the tabular format in the browser, with the 2D molecular structure and a radar plot summarizing the physicochemical quality of the compound. For those endpoints predicted by the regression models, such as Caco-2 permeability, plasma protein binding, etc., concrete predictive values are provided. For the endpoints predicted by the classification models, such as Pgp-inhibitor, hERG Blocker, etc., the prediction probability values are transformed into six symbols: 0-0.1(−−−), 0.1-0.3(−−), 0.3-0.5(−), 0.5-0.7(+), 0.7-0.9(++), and 0.9-1.0(+++). Usually, the token ‘+++’ or ‘++’ represents the molecule is more likely to be toxic or defective, while ‘−−−’ or ‘−−’ represents nontoxic or appropriate. Here, we do not recommend trusting predictions symbolled by ‘+’ or ‘−' (probably values in 0.3-0.7), and corresponding molecules require further assessment. The substructural rules available in the webserver, such as PAINS, SureChEMBL Rule, etc., were implemented using the SMARTS recognition capability of RDKit function. And the calculation of physicochemical and medicinal chemistry endpoints was based on the python library Scopy (18 ), following the parameters reported in corresponding original papers strictly. If the number of alerts is not zero, users can click the DETAIL button to check the undesirable substructures in the molecule. Finally, the full result file can be downloaded from the website in CSV or PDF format.
In the Screening pattern, two molecular submission approaches are provided by entering a list of SMILES strings or uploading a SDF or TXT formatted file. It should be noted that the file should only contain molecules without column headers and molecular indexes, otherwise the server may declare invalid input type. After all the predictions are completed, the results for each input molecule will be presented on a separate row, containing the assigned index, SMILES string, 2D molecular structure, and a View button. The prediction details can be accessed by clicking the View button of the corresponding molecule that links to the single-molecule evaluation page. These results can also be downloaded as a CSV-formatted file to the user's computer, where concrete probably values of classification endpoints are provided to enable the users to define their own thresholds to filter out deficient compounds with different levels of reliability. A typical ADMETlab 2.0 task for 1000 molecules requires ∼84 s, but it may also depend on the complexity of molecules.
Full text: Click here
Publication 2021
cDNA Library Molecular Structure Pain Permeability Plasma Plasma Proteins Python

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
Gene Expression Genes Microsatellite Instability Neoplasm Metastasis Neoplasms Patients Recurrence
eQuilibrator source code is freely available on Google Code (http://code.google.com/p/milo-lab/). The eQuilibrator web interface is composed of a back-end implemented in Python and a user interface implemented with HTML, CSS and JavaScript. A wide range of open software and databases significantly aid the development and maintenance of eQuilibrator. Non-thermodynamic data including compound names, masses and formulae, enzyme names, EC classes and catalyzed reactions are drawn from KEGG (17 (link)) and stored in a MySQL database. Thermodynamic data is drawn from several sources (11 ,23 ,24 (link)) and is stored in the same database. The Django framework is used to simplify database setup and querying, HTML generation, and web serving. Search queries are parsed via the pyparsing library and search results are ranked according to the degree to which they match the search query, where the degree of matching is computed using the edit-distance algorithm. The user interface is implemented using standard HTML and CSS. The dynamic portions of the interface, including real-time search suggestions, are implemented in JavaScript using the jQuery framework.
Thermodynamic data is available for download in standard formats—JavaScript Object Notation (JSON) and Comma-Separated Values (CSV)—and is provided at several levels of granularity. Files containing compound ΔfG′° and reaction ΔrG′° values at various combinations of pH and ionic strength are available. For those interested in detailed analyses involving varying cellular pH and ionic strength, files containing ΔfG° values for the various protonation states of KEGG compounds are also available.
Publication 2011
cDNA Library Cells Cytoplasmic Granules Enzymes Python Sorghum bicolor
At this stage, the uploaded data is compiled into a table in which each sample is formally represented by a row and each feature identifies a column. With the data structured in this format, two types of data normalization protocols—row-wise normalization and column-wise normalization—may be used. These are often applied sequentially to reduce systematic variance and to improve the performance for downstream statistical analysis. Row-wise normalization aims to normalize each sample (row) so that it is comparable to the other. Four commonly used metabolomic normalization methods have been implemented in MetaboAnalyst, including normalization to a constant sum, normalization to a reference sample (probabilistic quotient normalization) (17 (link)), normalization to a reference feature (creatinine or an internal standard) and sample-specific normalization (dry weight or tissue volume). In contrast to row-wise normalization, column-wise normalization aims to make each feature (column) more comparable in magnitude to the other. Four widely-used methods are offered in MetaboAnalyst—log transformation, auto-scaling, Pareto scaling and range scaling. Given the vast dynamic range of many features (compound concentration or ion abundance) in metabolomics data, normalization is highly recommended. The effects and utility of these different normalization strategies have been discussed in detail elsewhere (18 (link)) and are described further in MetaboAnalyst's online tutorials.
Publication 2009
Creatinine Tissues
PET: 18F T807 (AV1451) was prepared at MGH with a radiochemical yield of 14±3% and specific activity of 216±60 GBq/µmol at the end of synthesis (60min), and validated for human use.21 11C Pittsburgh Compound B was prepared and PET data were acquired as described previously.16 (link) All PET data were acquired using a Siemens/CTI (Knoxville, TN) ECAT HR+ scanner (3D mode; 63 image planes; 15.2cm axial field of view; 5.6mm transaxial resolution and 2.4mm slice interval. 11C PiB PET was acquired with a 8.5 to 15 mCi bolus injection followed immediately by a 60-minute dynamic acquisition in 69 frames (12×15 seconds, 57×60 seconds). 18F T807 was acquired from 80–100 minutes after a 9.0 to 11.0 mCi bolus injection in 4 × 5-minute frames. PET data were reconstructed and attenuation corrected, and each frame was evaluated to verify adequate count statistics and absence of head motion. The mean ± standard deviation (SD) lag time between 18F T807 and MMSE and CDR ratings was 4.9 ± 3.5 months, and between 18F T807 and 11C PiB PET imaging, 3.5 ± 2.6 months.
MRI was performed on a 3T Tim Trio (Siemens) and included a magnetization-prepared rapid gradient-echo (MPRAGE) processed with Freesurfer (FS) as described previously to identify grey-white and pial surfaces to permit ROI parcellation as follows: cerebellar grey, hippocampus, and the following Braak Stage related cortices: entorhinal (ER), parahippocampal (PH), inferior temporal (IT), fusiform (FF), posterior cingulate (PC), as described previously.16 (link), 22 –25 (link)To evaluate the anatomy of cortical T807 binding, each individual PET data set was rigidly co-registered to the subject’s MPRAGE data using SPM8 (Wellcome Department of Cognitive Neurology, Function Imaging Laboratory, London). The cortical ribbon and subcortical ROIs defined by MR as described above were transformed into the PET native space; PET data were sampled within each right-left ROI pair. SUVR values were represented graphically on vertices at the pial surface. PET data were not partial volume corrected.
18F T807 specific binding was expressed in FS ROIs as the standardized uptake value ratio (SUVR) to cerebellum, similar to a previous report, using the FS cerebellar grey ROI as reference. For voxel-wise analyses, each subject’s MPRAGE was registered to the template MR in SPM8 (SPM), and the spatially transformed SUVR PET data was smoothed with a 8 mm Gaussian kernel to account for individual anatomic differences.7 (link)11C PiB PET data were expressed as the distribution volume ratio (DVR) with cerebellar grey as reference tissue; regional time-activity curves (TAC) were used to compute regional DVRs for each ROI using the Logan graphical method applied to data from 40 to 60 minutes after injection.16 (link), 26 (link)11C PiB retention was assessed using a large cortical ROI aggregate that included frontal, lateral temporal and retrosplenial cortices (FLR) as described previously.17 (link), 27
Publication 2015

Most recents protocols related to «Compound 17»

Not available on PMC !

Example 16

[Figure (not displayed)]
1) Synthesis of Compound 17-1

[Figure (not displayed)]

Propionyl chloride (12.91 g, 139.50 mmol) was added to a solution of Compound 11-1 (10.00 g, 46.50 mmol) in trichloromethane (200 mL) at 20° C. The reaction mixture was heated to 70° C., and reacted for 12 h. The reaction mixture was cooled to room temperature, and concentrated to obtain a crude product. Ethyl acetate (100 mL) was added to the crude product and the resulting mixture was stirred at 25° C. for 0.5 h, and filtered. The collected filter cake was dried in a drying oven to obtain Compound 17-1. LCMS (ESI) m/z: 253 (M+1).

2) Synthesis of Compound 17-2

[Figure (not displayed)]

2-Bromoethanol (1.24 g, 9.88 mmol, 0.7 mL) was added to a mixed solution of Compound 17-1 (1.00 g, 3.95 mmol), potassium carbonate (1.36 g, 9.88 mmol), benzyltriethylammonium chloride (90 mg, 395.00 μmol), and dimethoxyethane (20 mL). The resulting reaction mixture was heated to 90° C., and stirred for 16 h. 2-Bromoethanol (1.24 g, 9.88 mmol, 0.7 mL) and benzyltriethylammonium chloride (135 mg, 592.70 μmol) were supplemented to the reaction mixture. The resulting reaction mixture was heated to 90° C., and stirred for 16 h. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue obtained from the concentration was purified by a silica gel column to obtain Compound 17-2. 1H NMR (400 MHz, CDCl3) δ ppm 8.30 (d, J=2.0 Hz, 1H), 7.87 (dd, J=2.3, 8.8 Hz, 1H), 7.75 (d, J=8.8 Hz, 1H), 4.80-4.72 (m, 2H), 4.08 (br d, J=3.5 Hz, 2H), 3.31 (br s, 1H), 2.96 (q, J=7.5 Hz, 2H), 1.40 (t, J=7.7 Hz, 3H).

3) Synthesis of Compound 17-3

[Figure (not displayed)]

diBoc (171 mg, 783.51 μmol), triethylamine (139 mg, 1.37 mmol, 0.19 mL), and 4-dimethylaminopyridine (10 mg, 81.85 μmol) were added to a mixed solution of Compound 17-2 (200 mg, 673.06 μmol) in dichloromethane (4 mL). The resulting reaction mixture was stirred at 10° C. for 1 h. The reaction mixture was concentrated under reduced pressure. The residue obtained from the concentration was purified by a silica gel column to obtain Compound 17-3. LCMS (ESI) m/z: 397 (M+1).

4) Synthesis of Compound 17-4

[Figure (not displayed)]

A mixture of Compound 17-3 (130 mg, 327.24 μmol), Boc-NH2 (50 mg, 426.80 μmol), cesium carbonate (266 mg, 816.40 μmol), bis(dibenzylideneacetone)palladium (20 mg, 34.78 μmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (20 mg, 34.56 μmol), and methylbenzene (2 mL) was added to a microwave tube, and kept at 120° C. for microwave reaction for 0.5 h. The reaction mixture was filtered through Celite. The filtrate was diluted with ethyl acetate (30 mL), washed with water (20 mL) and saturated brine (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue obtained from the concentration was purified by a preparative TLC plate to obtain Compound 17-4. LCMS (ESI) m/z: 434 (M+1).

5) Synthesis of Compound 17-5

[Figure (not displayed)]

Trifluoroacetic acid (0.2 mL) was added to a solution of Compound 17-4 (85 mg, 196.08 μmol) in dichloromethane (2 mL). The resulting reaction mixture was stirred at 15° C. for 12 h. A saturated aqueous solution of sodium bicarbonate was added to the reaction mixture (pH about 8), which was extracted with dichloromethane (20 mL). The organic phase was washed with saturated brine (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. Lithium hydroxide (82 mg, 1.95 mmol) was added to a solution of the resulting yellow oil (64 mg, 194.37 μmol) in tetrahydrofuran (2 mL) and water (0.5 mL). The resulting reaction mixture was stirred at 15° C. for 16 h. The reaction mixture was dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain Compound 17-5. LCMS (ESI) m/z: 234 (M+1).

6) Synthesis of Compound 17-6

[Figure (not displayed)]

Trimethylsilyl cyanide (25 mg, 252.00 μmol) and zinc chloride (4 mg, 29.32 μmol) were added to a mixed solution of Compound 17-5 (20 mg, 85.74 μmol), cyclobutanone (36 mg, 513.63 μmol), sodium sulfate (50 mg, 352.01 μmol) and tetrahydrofuran (2 mL). The resulting reaction mixture was stirred at 10° C. for 19 h. An aqueous solution of sodium sulfite (5 mL) was added to the reaction mixture, which was extracted with ethyl acetate (5 mL×3). The organic phase was washed with saturated brine (10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain Compound 17-6. LCMS (ESI) m/z: 313 (M+1).

7) Synthesis of Compound 17-7

[Figure (not displayed)]

diBoc (23 mg, 105.39 μmol), triethylamine (20 mg, 197.65 μmol), and 4-dimethylaminopyridine (2 mg, 16.37 μmol) were added to a mixed solution of Compound 17-6 (30 mg, 96.04 μmol) in dichloromethane (1 mL). The resulting reaction mixture was stirred at 10° C. for 1 h. The reaction mixture was concentrated under reduced pressure. The residue obtained from the concentration was purified by a preparative TLC plate to obtain Compound 17-7. LCMS (ESI) m/z: 413 (M+1).

8) Synthesis of Compound 17-8

[Figure (not displayed)]

A mixed solution of Compound 17-7 (20 mg, 48.49 μmol), Compound 1-7 (28 mg, 122.70 μmol), methylbenzene (1 mL), and DMF (0.2 mL) was heated to 110° C., and stirred for 16 h. Compound 1-7 (54 mg, 236.64 μmol) was supplemented to the reaction mixture, and the resulting mixture was further stirred at 110° C. for 4 h. Methanol (1 mL) was added to the reaction mixture, which was stirred for 30 min, and then concentrated under reduced pressure. The residue obtained from the concentration was purified by a preparative TLC plate (petroleum ether/ethyl acetate=1/1) to obtain Compound 17-8. LCMS (ESI) m/z: 642 (M+1).

9) Synthesis of Compound 17

[Figure (not displayed)]

Trifluoroacetic acid (0.2 mL) was added to a solution of Compound 17-8 (30 mg, 46.75 μmol) in dichloromethane (1 mL). The resulting reaction mixture was stirred at 10° C. for 2 h. A saturated aqueous solution of sodium bicarbonate was added to the reaction mixture (pH about 8), which was extracted with dichloromethane (10 mL×3). The organic phase was washed with saturated brine (15 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue obtained from the concentration was purified by a preparative TLC plate to obtain Compound 17. 1H NMR (400 MHz, CDCl3) δ ppm 8.09 (d, J=2.3 Hz, 1H), 8.01 (d, J=8.8 Hz, 1H), 7.92 (dd, J=3.1, 5.1 Hz, 2H), 7.80 (dd, J=1.8, 8.3 Hz, 1H), 7.64 (dd, J=2.5, 8.8 Hz, 1H), 4.77-4.69 (m, 2H), 4.07-3.98 (m, 2H), 3.12-2.81 (m, 3H), 2.73-2.62 (m, 2H), 2.59-2.46 (m, 2H), 2.26-2.13 (m, 1H), 1.65-1.55 (m, 1H), 1.38-1.33 (m, 3H); LCMS (ESI) m/z: 542 (M+1).

Full text: Click here
Patent 2024
Not available on PMC !

Example 20

[Figure (not displayed)]

To a solution of compound 16 (1.01 g, 1.87 mmol) in methanol (15 mL) was added 0.1N HCl dropwise until a neutral pH was reached. After addition of Pd/C (10 wt %, 583 mg), the mixture was stirred under H2 (1 atm) at room temperature for 16 h. The Pd/C was then removed by filtration, with washing of the filter pad with methanol. The filtrate was concentrated under reduced pressure and the residue was re-dissolved in EtOAc (50 mL), dried over anhydrous Na2SO4, filtered and concentrated to afford compound 17 (900 mg, 94% yield) as a pale yellow oil.

Full text: Click here
Patent 2024
Anabolism compound 17 Filtration Methanol Pressure

Example 17

[Figure (not displayed)]

To a solution of compound 17-1 (50 mg, 0.14 mmol, 1 eq) in DCM (1 mL) was added TEA (27.2 mg, 0.27 mmol, 37.4 uL, 2 eq) and acetyl acetate (20.6 mg, 0.2 mmol, 18.9 uL, 1.5 eq). The mixture was stirred at 20° C. for 1 hr. LCMS showed that 85% of desired product was detected. The reaction mixture was concentrated in vacuum. The crude product was purified by prep-HPLC. The title compound (28 mg, 64.9 umol, 48.3% yield) was obtained as a white solid. LCMS (ESI): RT=0.787 min, mass calcd. For C23H21F3N2O2, 414.16 m/z found 437.0 [M+Na]+; 1H NMR (400 MHz, CHLOROFORM-d) δ 8.49 (s, 1H), 7.91-8.12 (m, 2H), 7.70-7.82 (m, 3H), 7.60 (br s, 1H), 7.51 (br d, J=7.76 Hz, 2H), 7.44 (br d, J=7.76 Hz, 1H), 6.24 (br d, J=7.64 Hz, 1H), 4.33 (dq, J=13.59, 6.74 Hz, 1H), 2.39 (s, 3H), 1.32 (d, J=6.50 Hz, 6H).

Full text: Click here
Patent 2024
1H NMR Acetate Chloroform compound 17 High-Performance Liquid Chromatographies Lincomycin Vacuum
In a 250 mL glass round-bottom flask charged with a magnetic stir bar and placed under inert conditions (argon atmosphere), compound 16 (1 equiv., 4.51 mmol, 0.9892 g) was dissolved in anhydrous CH2Cl2 (100 mL) followed by the addition of DMP (1.1 equiv., 4.96 mmol, 2.1037 g). The mixture reacted at rt for 1 h and a white precipitate was formed, which was collected by gravity filtration and discarded. The filtrate was evaporated to dryness under reduced pressure and purified by liquid chromatography on a silica gel column using hexane/AcOEt (1 : 1 v/v) as eluent. Yellowish oil, η = 63% (0.6169 g, 2.84 mmol); 1H-NMR (400 MHz, DMSO-d6) δH 1.84 (2H, p, J = 7.0 Hz), 2.54–2.51 (2H, m), 3.59 (2H, t, J = 6.8 Hz), 7.88–7.81 (4H, m), 9.64 (1H, t, J = 1.1 Hz); 13C-NMR (100 MHz, DMSO-d6) δC 20.61, 36.77, 122.96, 131.65, 134.30, 167.97, 200.46; Rf, 0.61 in hexane/AcOEt 1 : 1 (v/v).
Full text: Click here
Publication 2024

Example 17

[Figure (not displayed)]

3-Bromo-5,6-dihydropyridin-2 (1H)-one (Compound 17d) (0.22 g, 1.25 mmol) was added into a 25-mL round-bottom flask under argon atmosphere, and charged with tetrahydrofuran (2.0 mL). Then, the temperature was lowered to −78° C., and LDA (0.63 mL, 1.25 mmol, 2.0 M solution) was added dropwise, followed by stirring for 45 minutes. (E)-3-(3-nitrophenyl)acryloyl chloride (Compound 17c) (0.22 g, 1.04 mmol) dissolved in tetrahydrofuran (1.50 mL) was slowly added at −78° C., followed by stirring for 1 hour. Upon the completion of the reaction, the remaining LDA was decomposed by 1 N hydrochloric acid, followed by extraction twice with ethyl acetate. The ethyl acetate layer was washed once with a saturated sodium chloride solution, dried over anhydrous sodium sulfate, evaporated under reduced pressure, and then separated by column chromatography (ethyl acetate/hexane=1/2.5 to 1/2), to give (E)-3-bromo-1-(3-(3-nitrophenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one (Compound 17) (110 mg, 30.1%) as a pale yellow solid.

1H NMR (400 MHz, Chloroform-d) δ 8.40 (t, J=2.0 Hz, 1H), 8.22 (ddd, J=8.1, 2.3, 1.0 Hz, 1H), 7.90 (d, J=7.6 Hz, 1H), 7.75 (d, J=15.6 Hz, 1H), 7.62-7.53 (m, 2H), 7.39 (t, J=4.6 Hz, 1H), 4.12 (t, J=6.5 Hz, 2H), 2.56 (td, J=6.4, 4.6 Hz, 2H).

Full text: Click here
Patent 2024
1H NMR acryloyl chloride Anabolism Argon Atmosphere Chloroform Chromatography compound 17 ethyl acetate Hexanes Hydrochloric acid Pressure Saline Solution sodium sulfate tetrahydrofuran

Top products related to «Compound 17»

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in United States, Japan, Netherlands, Germany, France, United Kingdom
Tissue-Tek OCT compound is a tissue-embedding medium designed for cryosectioning. It is formulated to provide optimal support and preservation of tissue samples during the freezing process, enabling the production of high-quality frozen sections for microscopic analysis.
Sourced in United States, Germany
Compound Discoverer 3.1 is a software solution for identifying and characterizing small molecules in complex samples. It provides a comprehensive data processing and analysis workflow for high-resolution mass spectrometry data.
Sourced in United States, United Kingdom, Canada, China, Germany, Japan, Belgium, Israel, Lao People's Democratic Republic, Italy, France, Austria, Sweden, Switzerland, Ireland, Finland
Prism 6 is a data analysis and graphing software developed by GraphPad. It provides tools for curve fitting, statistical analysis, and data visualization.
Sourced in Japan, United States, Netherlands, Germany, Switzerland, United Kingdom, France
The OCT compound is a specialized laboratory equipment designed for optical coherence tomography (OCT) analysis. It enables high-resolution, non-invasive imaging of biological samples by utilizing low-coherence interferometry. The core function of the OCT compound is to capture detailed, cross-sectional images of various materials and tissues.
Sourced in United States, Hungary
AutoDock Tools is a software suite designed to perform molecular docking simulations. It provides a graphical user interface (GUI) for preparing input files, running docking calculations, and analyzing the results. The core function of AutoDock Tools is to predict the preferred binding orientations and affinities between a small molecule and a target protein.
Sourced in United States, Italy, Japan, Germany
The Gemini C18 is a reversed-phase liquid chromatography column designed for the separation and analysis of a wide range of organic compounds. It features a fully porous silica-based stationary phase with a C18 alkyl bonded ligand. The column is capable of operating at high pressure and temperature conditions, making it suitable for a variety of analytical applications.
Sourced in United States, Austria, Germany, Poland, United Kingdom, Canada, Japan, Belgium, China, Lao People's Democratic Republic, France
Prism 9 is a powerful data analysis and graphing software developed by GraphPad. It provides a suite of tools for organizing, analyzing, and visualizing scientific data. Prism 9 offers a range of analysis methods, including curve fitting, statistical tests, and data transformation, to help researchers and scientists interpret their data effectively.
Sourced in United States, Germany, France
The Compound Discoverer 2.0 is a powerful analytical software solution designed for compound identification and characterization. It integrates advanced algorithms and data processing capabilities to assist in the detection, identification, and quantification of chemical compounds from complex samples.

More about "Compound 17"

Compound 17 is a chemical compound of significant interest in the field of biomedical research.
This versatile molecule has been the subject of extensive investigation, with researchers exploring its potential applications across various domains.
Beyond its primary identification as Compound 17, this substance is also known by several other names and abbreviations, including C17, C-17, and Cmpd 17.
These alternative designations are often used interchangeably within the scientific community, depending on the specific context and preferences of individual researchers.
In addition to Compound 17, there are several other related compounds and chemical entities that may be of relevance to this area of study.
For instance, FBS (Fetal Bovine Serum), DMSO (Dimethyl Sulfoxide), and Tissue-Tek OCT Compound are commonly utilized in laboratory procedures involving Compound 17 and similar bioactive substances.
Researchers leveraging advanced analytical tools, such as Compound Discoverer 3.1, Prism 6, and AutoDock Tools, have been able to delve deeper into the properties and behavior of Compound 17, unlocking valuable insights that drive the progression of their research.
Furthermore, techniques like Gemini C18 chromatography and the use of Prism 9 software have enabled researchers to effectively characterize and study this chemical entity.
By exploring the wealth of information and resources available, scientists can optimize their Compound 17 research protocols, identify the most promising approaches, and accelerate their investigations into this intriguing and potentially impactful biomedical compound.
The PubCompare.ai platform, with its AI-powered capabilities, can be a valuable tool in this endeavor, empowering researchers to make informed decisions and advance their work with confidence.